BioCentury | Jan 23, 2021
Emerging Company Profile

Technology showcase: BioCentury’s 2020 class of emerging companies

...frameborder="0" scrolling="no" style="width:100%;height:535px;"> Two biotechs — Graphite Bio Inc. and Spotlight Therapeutics Inc. ...
BioCentury | Dec 1, 2020
Emerging Company Profile

Spotlight: solving CRISPR’s delivery challenges with RNPs

...millionInvestors: GV, undisclosedCEO: Mary Haak-FrendschoPatents: None issued Lauren Martz Spotlight Therapeutics Inc. Intellia...
BioCentury | May 8, 2020
Targets & Mechanisms

New Gladstone institutes point to emerging concepts in virology, immunology

...is co-founder of cancer immunotherapy newco Arsenal Biosciences Inc. and in vivo gene editing company Spotlight Therapeutics Inc. Karen...
BioCentury | Aug 8, 2019
Distillery Techniques

Model to predict CRISPR repair outcomes in T cells

...TECHNIQUES CATEGORY: Other TECHNOLOGY: Computational models Researchers from the Chan Zuckerberg Biohub, including co-founders of Spotlight Therapeutics Inc....
...James Zou, Chan Zuckerberg Biohub, San Francisco, Calif. e-mail: jamesz@stanford.edu Karen Tkach Tuzman Arsenal Biosciences Inc. Chan Zuckerberg Biohub Spotlight Therapeutics Inc. Stanford...
BioCentury | Jul 31, 2019
Preclinical News

July 31 Preclinical Quick Takes: Sangamo reveals new gene editors; plus a CRISPR prediction model and vaccine boosters for ischemia

...donors, but differed across target sites. Authors included co-founders of cell type-specific gene editing company Spotlight Therapeutics Inc....
...TRAC - T cell receptor alpha constant Karen Tkach Tuzman, Associate Editor Chan Zuckerberg Biohub Harvard University Sangamo Therapeutics Inc. Spotlight Therapeutics Inc. Wyss...
BioCentury | Nov 17, 2018
Preclinical News

Spotlight co-founder uses CRISPR screen to ID T cell regulator genes for cancer

...connect gene variants with diseases in different immune cells. Mark Zipkin La Jolla Institute for Allergy & Immunology Spotlight Therapeutics Inc. University...
Items per page:
1 - 6 of 6
BioCentury | Jan 23, 2021
Emerging Company Profile

Technology showcase: BioCentury’s 2020 class of emerging companies

...frameborder="0" scrolling="no" style="width:100%;height:535px;"> Two biotechs — Graphite Bio Inc. and Spotlight Therapeutics Inc. ...
BioCentury | Dec 1, 2020
Emerging Company Profile

Spotlight: solving CRISPR’s delivery challenges with RNPs

...millionInvestors: GV, undisclosedCEO: Mary Haak-FrendschoPatents: None issued Lauren Martz Spotlight Therapeutics Inc. Intellia...
BioCentury | May 8, 2020
Targets & Mechanisms

New Gladstone institutes point to emerging concepts in virology, immunology

...is co-founder of cancer immunotherapy newco Arsenal Biosciences Inc. and in vivo gene editing company Spotlight Therapeutics Inc. Karen...
BioCentury | Aug 8, 2019
Distillery Techniques

Model to predict CRISPR repair outcomes in T cells

...TECHNIQUES CATEGORY: Other TECHNOLOGY: Computational models Researchers from the Chan Zuckerberg Biohub, including co-founders of Spotlight Therapeutics Inc....
...James Zou, Chan Zuckerberg Biohub, San Francisco, Calif. e-mail: jamesz@stanford.edu Karen Tkach Tuzman Arsenal Biosciences Inc. Chan Zuckerberg Biohub Spotlight Therapeutics Inc. Stanford...
BioCentury | Jul 31, 2019
Preclinical News

July 31 Preclinical Quick Takes: Sangamo reveals new gene editors; plus a CRISPR prediction model and vaccine boosters for ischemia

...donors, but differed across target sites. Authors included co-founders of cell type-specific gene editing company Spotlight Therapeutics Inc....
...TRAC - T cell receptor alpha constant Karen Tkach Tuzman, Associate Editor Chan Zuckerberg Biohub Harvard University Sangamo Therapeutics Inc. Spotlight Therapeutics Inc. Wyss...
BioCentury | Nov 17, 2018
Preclinical News

Spotlight co-founder uses CRISPR screen to ID T cell regulator genes for cancer

...connect gene variants with diseases in different immune cells. Mark Zipkin La Jolla Institute for Allergy & Immunology Spotlight Therapeutics Inc. University...
Items per page:
1 - 6 of 6